Back to News
Market Impact: 0.2
Legend Biotech Appoints Ingrid Zhang As CEO
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Legend Biotech appointed Ingrid Zhang as chief executive officer, effective September 15. The announcement is a leadership transition at the cell-therapy company, with no financial guidance, operating metrics, or strategic changes disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
LEGN0.20
More News
- The big questions remaining after Anthropic’s blockbuster IPO prospectus
- Illumina CEO on Q3 Results and Business Outlook
- UnitedHealth is finally getting its act together. I'm buying into the turnaround
- Swiss Firms Plan Investment Boost in China Drug, Finance Sectors
- Bernstein SocGen raises Eli Lilly stock price target on strong Q3 beat
- Freedom Broker raises Eli Lilly stock price target on GLP-1 demand